PUBLISHER: TechNavio | PRODUCT CODE: 1144289
PUBLISHER: TechNavio | PRODUCT CODE: 1144289
Technavio has been monitoring the glucosamine market and it is poised to grow by $244.19 mn during 2022-2026, accelerating at a CAGR of 5.75% during the forecast period. Our report on the glucosamine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing adoption of healthy eating habits, increasing number of vegan consumers, and consumer awareness regarding joint and bone health.
The glucosamine market analysis includes the application segment and geographic landscape.
Technavio's glucosamine market is segmented as below:
By Application
By Geographical Landscape
This study identifies the increase in elderly population as one of the prime reasons driving the glucosamine market growth during the next few years. Also, increasing investments in R&D and rapidly growing healthcare industry will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on glucosamine market covers the following areas:
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading glucosamine market vendors that include Cargill Inc., Ethical Naturals Inc., Foodchem International Corp., GoldenShell Pharmaceutical, Jiaxing Hengjie Biopharmaceutical Co., Ltd., KOYO CHEMICAL CO., LTD., NOW Health Group Inc., NutraLife, Panvo Organics Pvt. Ltd., Reckitt Benckiser Group PLC, STELLAR BIOSOL, TSI Group Ltd., Viatris Inc., Wellable Marine Biotech Holding Ltd, Yang Zhou Rixing Biotech Co Ltd, Yantai Dongcheng Pharmaceutical Group Co. Ltd, Zhejiang Aoxing Biotechnology Co. LTD., Zhejiang Chengyi Pharmaceutical Co., Ltd., Zhejiang Kangduoli Pharmaceutical Co. Ltd, and Cellmark AB. Also, the glucosamine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: